Search clinical trials for: Ad26.COV2.S (Janssen)
Total 50 results
-
Alvea Holdings, LLCCompletedSars-CoV-2 InfectionSouth Africa
-
Centre Hospitalier Universitaire de Saint EtienneActive, not recruiting
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; APHP; Center... and other collaboratorsActive, not recruitingCOVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | SARS CoV 2 InfectionMali
-
AstraZenecaCompleted
-
Indiana UniversityTerminated
-
University Hospital, CaenCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedCoronavirus Disease-2019 (COVID-19) PreventionMexico, South Africa, Brazil, Argentina, India
-
Mark StegallJanssen Scientific Affairs, LLCActive, not recruitingKidney Transplant RecipientUnited States
-
Janssen Vaccines & Prevention B.V.CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOVID-19 PreventionUnited States, Germany, Brazil, Poland, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, South Africa, Brazil
-
University Medical Center GroningenRadboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaboratorsCompletedKidney Diseases | Covid19 | SARS-CoV2 Infection | Vaccine Response ImpairedNetherlands
-
Janssen Research & Development, LLCNo longer available
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
University of OxfordEnrolling by invitationTuberculosis | Covid-19 PandemicsThailand
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, Belgium, Poland
-
The Aurum Institute NPCCoalition for Epidemic Preparedness InnovationsRecruiting
-
Mahidol UniversityJanssen Pharmaceuticals; International Vaccine Institute; National Vaccine Institute...RecruitingSARS-CoV-2 InfectionThailand
-
Wits Health Consortium (Pty) LtdFred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaboratorsCompletedSARS (Severe Acute Respiratory Syndrome)South Africa
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States
-
International Vaccine InstituteHeidelberg University; International Centre for Diarrhoeal Disease Research... and other collaboratorsActive, not recruitingCovid19Madagascar, Mozambique
-
Karaganda Medical UniversityMcMaster UniversityCompletedCovid19 | Vaccine Adverse ReactionKazakhstan
-
Hospital Moinhos de VentoPfizer; Universidade Federal do Paraná; Inova MedicalCompleted
-
Massachusetts General HospitalCompletedChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
R-PharmAstraZeneca; Russian Direct Investment Fund; The Gamaleya National Center of...Completed
-
SolAeroMed Inc.SuspendedCovid19 | SARS-CoV-2 InfectionCanada
-
Binhui Biopharmaceutical Co., Ltd.Recruiting
-
Hanyang University Seoul HospitalSeegene Medical FoundationCompletedCovid19 | Vaccine Reaction | Hemolysis | End-stage Renal DiseaseKorea, Republic of
-
R-PharmAstraZenecaCompleted
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Autoimmunity Centers of ExcellenceCompletedSystemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)United States
-
R-PharmAstraZeneca; Russian Direct Investment Fund; The Gamaleya National Center of...Completed
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; Institut...Not yet recruitingCOVID-19Burkina Faso, Chad, Congo, Côte D'Ivoire, Gabon, Mali
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
Baskent UniversityHikmet Eda Aliskan; Hatice Hale Gumus; Ilker Odemis; Zuhal Ekici UnsalCompleted
-
Laboratorio Avi-Mex, S.A. de C.V.National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...CompletedSARS-CoV-2 InfectionMexico
-
Vilnius UniversityRecruitingAnalysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed IndividualsHematologic Neoplasms | COVID-19 VaccinesLithuania
-
Clover Biopharmaceuticals AUS Pty LtdWithdrawn
-
D'Or Institute for Research and EducationBill and Melinda Gates Foundation; Instituto Fernandes FigueiraNot yet recruiting
-
University of Rome Tor VergataCompletedLiver Transplantation | SARS-CoV-2 VaccinationItaly
-
Canadian Immunization Research NetworkMassachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaboratorsActive, not recruiting
-
Netherlands Institute for Pigment DisordersAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Completed
-
Netherlands Institute for Pigment DisordersAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Completed
-
Netherlands Institute for Pigment DisordersCompletedLocal Anesthesia of the Skin
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany